Quantabia

🗓 Founded 2026👥 4 employees💰 Last funded Aug 2026
Biotechnology Research🌐 quantabia.com
Website LinkedIn
Quantabias mandate is localization. The company is building Saudi operations, Saudi talent, and Saudi reference datasets to deploy QES across four areas: biomanufacturing quality control, drug development, clinical biomarkers and population health, and biosecurity, including environmental surveillance and mass gathering health protection. In doing so, Quantabia establishes sovereign bioanalytic capacity inside the Kingdom, in direct alignment with Vision 2030 and the National Biotechnology Strategy. ProbiusDxs proprietary molecular identification technology leverages multiscale biological profiling (using Quantum Electrochemical Spectroscopy) to enable rapid biomarker detection with minimal sample preparation—positioning Quantabia to advance diagnostic capabilities and accelerate therapeutic discovery across the region.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2026
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Quantabia?
Quantabia has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Quantabia last raise funding?
The most recent investment in Quantabia recorded on gritt.io was in August 2026.
When was Quantabia founded?
Quantabia was founded in 2026.
What industry is Quantabia in?
Quantabia operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.